Occult Lymph Node Metastasis in Early-Stage Glottic Cancer in the National Cancer Database
Editor's Note: This Manuscript was accepted for publication on July 13, 2020.
The authors have no funding or conflicts of interest to declare.
Abstract
Objectives
Early-stage glottic cancer (cT1–T2 cN0) may be treated by primary surgery or radiation. Elective treatment of the neck in clinically N0 disease is usually not performed due to low rates of regional lymph node metastasis. This study examines the role of elective neck dissection (END) and rate of occult nodal metastasis in cT1–T2 cN0 glottic cancer treated with primary surgery.
Study Design
Retrospective cohort study.
Methods
The National Cancer Database was used to identify patients treated for early-stage glottic cancer. Demographic variables, disease characteristics, and overall survival were compared between the subgroups of patients who did and did not receive END. Factors predictive of occult lymph node metastasis were also identified using a multivariate logistic regression model.
Results
Thirty-eight percent of the 991 patients in this cohort underwent END. Younger age, treatment at an academic facility, advanced T-stage, and higher tumor grade were associated with receiving END. Sixteen percent of the 372 patients undergoing END had occult nodal metastasis. Higher tumor histopathologic grade was associated with occult metastasis (P = .004). While undergoing END did not affect significantly survival, those with occult metastasis had poorer survival (P < .001).
Conclusions
END should be considered in cT1–T2 N0 glottic cancers with poorly differentiated or undifferentiated tumor histopathology. While END itself may not improve overall survival, identification of occult nodal metastasis is an important finding for prognostication.
Level of Evidence
Level 3 Laryngoscope, 131:E1139–E1146, 2021
